These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11829725)

  • 1. Azithromycin for the treatment and control of trachoma.
    Burton MJ; Frick KD; Bailey RL; Bowman RJ
    Expert Opin Pharmacother; 2002 Feb; 3(2):113-20. PubMed ID: 11829725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled trial of single-dose azithromycin in treatment of trachoma.
    Bailey RL; Arullendran P; Whittle HC; Mabey DC
    Lancet; 1993 Aug; 342(8869):453-6. PubMed ID: 8102427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.
    Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF
    Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review.
    O'Brien KS; Emerson P; Hooper PJ; Reingold AL; Dennis EG; Keenan JD; Lietman TM; Oldenburg CE
    Lancet Infect Dis; 2019 Jan; 19(1):e14-e25. PubMed ID: 30292480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trachoma: a review.
    Tabbara KF
    J Chemother; 2001 Apr; 13 Suppl 1():18-22. PubMed ID: 11434524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis.
    Solomon AW; Mohammed Z; Massae PA; Shao JF; Foster A; Mabey DC; Peeling RW
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4804-6. PubMed ID: 16251338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin in control of trachoma.
    Schachter J; West SK; Mabey D; Dawson CR; Bobo L; Bailey R; Vitale S; Quinn TC; Sheta A; Sallam S; Mkocha H; Mabey D; Faal H
    Lancet; 1999 Aug; 354(9179):630-5. PubMed ID: 10466664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of antibiotic treatment on active trachoma and ocular Chlamydia trachomatis infection.
    Mabey D; Solomon A
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):209-16. PubMed ID: 15482115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
    Ramadhani AM; Derrick T; Macleod D; Massae P; Malisa A; Mbuya K; Mtuy T; Makupa W; Roberts CH; Bailey RL; Mabey DCW; Holland MJ; Burton MJ
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007559. PubMed ID: 31306419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass antibiotic treatment alone does not eliminate ocular chlamydial infection.
    Emerson PM; Ngondi J
    PLoS Negl Trop Dis; 2009; 3(3):e394. PubMed ID: 19333370
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic therapy for trachoma.
    Prescrire Int; 2009 Aug; 18(102):176-7. PubMed ID: 19750586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stopping azithromycin mass drug administration for trachoma: A systematic review.
    Mahmud H; Landskroner E; Amza A; Aragie S; Godwin WW; de Hostos Barth A; O'Brien KS; Lietman TM; Oldenburg CE
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009491. PubMed ID: 34237074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands.
    Marks M; Bottomley C; Tome H; Pitakaka R; Butcher R; Sokana O; Kako H; Solomon AW; Mabey DC
    Sex Transm Infect; 2016 Jun; 92(4):261-5. PubMed ID: 26888658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Chlamydia trachomatis infection: elimination with mass drug administration.
    Wolle MA; West SK
    Expert Rev Anti Infect Ther; 2019 Mar; 17(3):189-200. PubMed ID: 30698042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
    Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
    Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.
    Last AR; Burr SE; Harding-Esch E; Cassama E; Nabicassa M; Roberts CH; Mabey DCW; Holland MJ; Bailey RL
    Parasit Vectors; 2017 Dec; 10(1):624. PubMed ID: 29282126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of blinding trachoma.
    Schachter J; Dawson CR
    Curr Opin Infect Dis; 2002 Oct; 15(5):491-5. PubMed ID: 12686881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali.
    Schémann JF; Guinot C; Traore L; Zefack G; Dembele M; Diallo I; Traore A; Vinard P; Malvy D
    Acta Trop; 2007 Jan; 101(1):40-53. PubMed ID: 17239332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community.
    West ES; Munoz B; Mkocha H; Holland MJ; Aguirre A; Solomon AW; Bailey R; Foster A; Mabey D; West SK
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):83-7. PubMed ID: 15623758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to control trachoma.
    Mathew AA; Turner A; Taylor HR
    Drugs; 2009 May; 69(8):953-70. PubMed ID: 19496626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.